NeoGenomics Inc. (NG9)
FSX
Real-time Data
06:00 AM
Day's Range
13.8752 wk Range
5.50Overview - NG9 - NeoGenomics Inc.
Key Statistics
Valuation
Enterprise Value
1.80B
P/E (Trailing)
‪-16.50‬
P/E (Forward)
‪-87.53‬
PEG Ratio
‪0.15‬
Price / Sales (TTM)
‪2.34‬
Price / Book
‪2.63‬
EV / EBITDA
‪86.41‬
Profitability
Gross Margin
‪45.56%‬
Profit Margin
‪-6.77%‬
Operating Margin
‪-4.84%‬
Return on Assets
‪-1.88%‬
Return on Equity
‪-6.32%‬
Ownership
Shares Outstanding
127.91M
Float
117.03M
Held by Insiders
‪2.06%‬
Held by Institutions
‪115.55%‬
Price stats
Beta
‪1.73‬
50-Day Avg
‪12.38‬
200-Day Avg
‪9.64‬
Dividends
Payout Ratio
‪0.00%‬
Peers - NG9 - NeoGenomics Inc.
Related Symbols
Other instruments in the same class.
Profile Summary - NG9 - NeoGenomics Inc.
About
NeoGenomics Inc. is a leading cancer diagnostics company specializing in oncology genetics testing and information services. It offers one of the most comprehensive menus of oncology-focused tests worldwide, including next-generation sequencing (NGS), comprehensive genomic profiling, and advanced assays like RaDaR ST…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
